186 related articles for article (PubMed ID: 25595223)
1. Ligand and structure-based approaches for the identification of SIRT1 activators.
Vyas VK; Goel A; Ghate M; Patel P
Chem Biol Interact; 2015 Feb; 228():9-17. PubMed ID: 25595223
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors.
Vyas VK; Ghate M; Goel A
J Mol Graph Model; 2013 May; 42():17-25. PubMed ID: 23507201
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity.
Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S
SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104
[TBL] [Abstract][Full Text] [Related]
4. In silico and in vitro identification of candidate SIRT1 activators from Indonesian medicinal plants compounds database.
Azminah A; Erlina L; Radji M; Mun'im A; Syahdi RR; Yanuar A
Comput Biol Chem; 2019 Dec; 83():107096. PubMed ID: 31377446
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore identification, docking and "in silico" screening for novel CDK1 inhibitors.
Dong X; Yan J; Du L; Wu P; Huang S; Liu T; Hu Y
J Mol Graph Model; 2012 Jul; 37():77-86. PubMed ID: 22622012
[TBL] [Abstract][Full Text] [Related]
6. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
Bhatt H; Patel P; Pannecouque C
Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anti-HIV activity of novel quinoxaline derivatives.
Patel SB; Patel BD; Pannecouque C; Bhatt HG
Eur J Med Chem; 2016 Jul; 117():230-40. PubMed ID: 27105027
[TBL] [Abstract][Full Text] [Related]
8. In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches.
Li RJ; Wang YL; Wang QH; Wang J; Cheng MS
Comput Math Methods Med; 2015; 2015():418767. PubMed ID: 25784957
[TBL] [Abstract][Full Text] [Related]
9. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1).
Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371
[TBL] [Abstract][Full Text] [Related]
10. Ligand-based pharmacophore modeling and Bayesian approaches to identify c-Src inhibitors.
Sakkiah S; Arullaperumal V; Hwang S; Lee KW
J Enzyme Inhib Med Chem; 2014 Feb; 29(1):69-80. PubMed ID: 23432516
[TBL] [Abstract][Full Text] [Related]
11.
Vaghefinezhad N; Farsani SF; Gharaghani S
Curr Drug Discov Technol; 2021; 18(1):139-157. PubMed ID: 31721705
[TBL] [Abstract][Full Text] [Related]
12. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
Jain V; Saravanan P; Arvind A; Mohan CG
Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
[TBL] [Abstract][Full Text] [Related]
13. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore based virtual screening, synthesis and SAR of novel inhibitors of Mycobacterium sulfotransferase.
Saha R; Tanwar O; Alam MM; Zaman MS; Khan SA; Akhter M
Bioorg Med Chem Lett; 2015 Feb; 25(3):701-7. PubMed ID: 25541388
[TBL] [Abstract][Full Text] [Related]
15. Combiphore (Structure and Ligand Based Pharmacophore) - Approach for the Design of GPR40 Modulators in the Management of Diabetes.
Gajjar KA; Gajjar AK
Curr Drug Discov Technol; 2020; 17(2):233-247. PubMed ID: 30306872
[TBL] [Abstract][Full Text] [Related]
16. In-Silico Screening of Ligand Based Pharmacophore, Database Mining and Molecular Docking on 2, 5-Diaminopyrimidines Azapurines as Potential Inhibitors of Glycogen Synthase Kinase-3β.
Mishra P; Kesar S; Paliwal SK; Chauhan M; Madan K
Cent Nerv Syst Agents Med Chem; 2018; 18(2):150-158. PubMed ID: 29848281
[TBL] [Abstract][Full Text] [Related]
17. Strategies for generating less toxic P-selectin inhibitors: pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits.
Ananthula RS; Ravikumar M; Pramod AB; Madala KK; Mahmood SK
J Mol Graph Model; 2008 Nov; 27(4):546-57. PubMed ID: 18993099
[TBL] [Abstract][Full Text] [Related]
18. In Silico Design of Novel Sirtuin 1 Enzyme Activators for the Treatment of Age-related Diseases and Life Span.
Ertan-Bolelli T; Bolelli K
Curr Comput Aided Drug Des; 2021; 17(3):412-420. PubMed ID: 32321406
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Akt1 allosteric site to identify novel scaffolds through virtual screening.
Yilmaz OG; Olmez EO; Ulgen KO
Comput Biol Chem; 2014 Feb; 48():1-13. PubMed ID: 24291487
[TBL] [Abstract][Full Text] [Related]
20. Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine.
Manna D; Bhuyan R; Ghosh R
J Mol Model; 2018 Nov; 24(12):340. PubMed ID: 30448921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
